ADGRG1: A Potential Drug Target and Biomarker for Diseases (G9289)

Target Name: ADGRG1

NCBI ID: G9289

ADGRG1

ADGRG1: A Potential Drug Target and Biomarker for Diseases

ADGRG1 (Adhesion G protein-coupled receptor G1, transcript variant 1) is a protein that is expressed in various tissues throughout the body, including the nervous system, endothelial cells, and epithelial cells. It is a member of the G protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling.

ADGRG1 is a GPCR that is involved in a wide range of physiological processes in the body, including cell adhesion, migration, and survival. It is also involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Drug Targeting

ADGRG1 is a drug target that has been identified as a potential therapeutic target for a wide range of diseases. One of the main reasons for its potential as a drug target is its involvement in several signaling pathways that are involved in various diseases.

For example, ADGRG1 is involved in the regulation of cell adhesion, which is a critical process that plays a role in the development and maintenance of tissues and organs. Mutations in the ADGRG1 gene have been associated with the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Additionally, ADGRG1 is involved in the regulation of cell migration, which is a critical process that is involved in the development and progression of many diseases, including cancer. Mutations in the ADGRG1 gene have been associated with the development of various cancers, including breast, ovarian, and colorectal cancers.

Another potential drug target for ADGRG1 is its role in the regulation of cellular survival. Mutations in the ADGRG1 gene have been associated with the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Biomarker

ADGRG1 is also a potential biomarker for several diseases. For example, it has been used as a biomarker for cancer, including breast, ovarian, and colorectal cancers. Additionally, ADGRG1 has been used as a biomarker for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

One of the main advantages of using ADGRG1 as a biomarker is its stability and high expression levels in different tissues. This makes it a potential biomarker that can be used to diagnose and monitor the progression of diseases.

Conclusion

ADGRG1 is a protein that is involved in a wide range of physiological processes in the body, including cell adhesion, migration, and survival. It is also involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. As a result, ADGRG1 is a drug target that has the potential to treat a wide range of diseases. Additionally, it is also a potential biomarker for several diseases. Further research is needed to fully understand the role of ADGRG1 in disease and to develop effective treatments.

Protein Name: Adhesion G Protein-coupled Receptor G1

Functions: Receptor involved in cell adhesion and probably in cell-cell interactions. Mediates cell matrix adhesion in developing neurons and hematopoietic stem cells. Receptor for collagen III/COL3A1 in the developing brain and involved in regulation of cortical development, specifically in maintenance of the pial basement membrane integrity and in cortical lamination (By similarity). Binding to the COL3A1 ligand inhibits neuronal migration and activates the RhoA pathway by coupling to GNA13 and possibly GNA12 (PubMed:22238662). Plays a role in the maintenance of hematopoietic stem cells and/or leukemia stem cells in bone marrow niche (By similarity). Plays a critical role in cancer progression by inhibiting VEGFA production threreby inhibiting angiogenesis through a signaling pathway mediated by PRKCA (PubMed:16757564, PubMed:21724588). Plays an essential role in testis development (By similarity)

The "ADGRG1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ADGRG1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets